EBMT-EHA CAR-T 2019 | Factors to consider by patients regarding CAR T-cell therapy
Monique Minnema
• 20 Mar 2019
Monique Minnema, PhD, from the University Medical Center, Utrecht, Netherlands, explains some key aspects of CAR T-cell therapy that patients should be aware of and the risks associated with the therapy. Recorded at the 1st European CAR T-Cell meeting in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).
